Evidence map›Paper›PMID 27298403›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Reply to F. Felix et al and M.F. Fay et al.

Caroline Happold, Thierry Gorlia, Oliver Chinot, Mark R Gilbert, L Burt Nabors, Wolfgang Wick, Stephanie L Pugh, Monika Hegi, Timothy Cloughesy, Patrick Roth and 5 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Caroline HappoldUniversity Hospital Zurich, Zurich, Switzerland.
Thierry GorliaEuropean Organisation for Research and Treatment of Cancer Data Centre, Brussels, Belgium.
Oliver ChinotAix-Marseille University, Marseille, France.
Mark R GilbertThe University of Texas MD Anderson Cancer Center, Houston, TX.
L Burt NaborsUniversity of Alabama at Birmingham, Birmingham, AL.
Wolfgang WickUniversity of Heidelberg; German Cancer Research Center, Heidelberg, Germany.
Stephanie L PughNRG Oncology Statistics and Data Management Center, Philadelphia, PA.
Monika HegiUniversity Hospital Lausanne, Lausanne, Switzerland.
Timothy CloughesyUniversity of California, Los Angeles, Los Angeles, CA.
Patrick RothUniversity Hospital Zurich, Zurich, Switzerland.
David A ReardonDana-Farber Cancer Institute, Boston, MA.
James R PerryUniversity of Toronto, Toronto, Ontario, Canada.
Minesh P MehtaUniversity of Maryland, Baltimore, MD.
Roger StuppUniversity Hospital Zurich, Zurich, Switzerland.
Michael WellerUniversity Hospital Zurich, Zurich, Switzerland michael.weller@usz.ch.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
RTOG Foreign AccrualU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI CURRAN, WALTER J. · 1985 to 2013
$150.3M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mei-Yin C Polley · 2014 to 2026
$146.4M
NCI NIH HHS U10 CA021661NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27298403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.